Our observations were similar to those from the study by Han et al. of 2091 PC patients reporting a BCR rate of 17% during 17 years of follow-up and utilizing the same cutpoint for serum PSA of 0.2 ng/mL to define BCR [35]. Here, KLK3 is linked to pachyonychia congenita.